Description

6H-Pyrazolo[3,4-B]Pyridin-6-One,3-Cyclobutyl-4-Ethyl-1,2,4,5-Tetrahydro-(9Ci) is a high-purity, advanced pharmaceutical intermediate belonging to the pyrazolopyridine class of heterocyclic compounds. Its complex, fused-ring structure makes it a valuable building block for medicinal chemistry research and the synthesis of novel active pharmaceutical ingredients (APIs). This compound is primarily sought by research institutions and pharmaceutical development companies engaged in drug discovery programs targeting central nervous system (CNS) disorders, oncology, and inflammation.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of potential drug candidates, particularly those with pyrazolopyridine scaffolds.
• Medicinal Chemistry Research: Used as a core structural motif for structure-activity relationship (SAR) studies and lead optimization in drug discovery.
• Biochemical Tool Compound: Employed in vitro and in vivo to study biological pathways and validate novel therapeutic targets.
• Contract Research & Development (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional labs for fundamental research in organic synthesis and heterocyclic chemistry.

Basic Information

Product Name	6H-Pyrazolo[3,4-B]Pyridin-6-One,3-Cyclobutyl-4-Ethyl-1,2,4,5-Tetrahydro-(9Ci)
CAS No.	817640-95-2
Molecular Formula	C12H17N3O
Molecular Weight	219.28 g/mol
Synonyms	3-Cyclobutyl-4-ethyl-1,2,4,5-tetrahydro-6H-pyrazolo[3,4-b]pyridin-6-one; 3-Cyclobutyl-4-ethyl-1,4,5,6-tetrahydro-2H-pyrazolo[3,4-b]pyridin-6-one; 6H-Pyrazolo[3,4-b]pyridin-6-one, 3-cyclobutyl-4-ethyl-1,2,4,5-tetrahydro-; Tetrahydro-pyrazolopyridinone derivative; Pyrazolo[3,4-b]pyridine-6-one intermediate; CAS 817640-95-2
EINECS	Contact for details

Quality Control

Our 6H-Pyrazolo[3,4-B]Pyridin-6-One,3-Cyclobutyl-4-Ethyl-1,2,4,5-Tetrahydro-(9Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with every shipment, detailing all critical specifications. Our quality commitment supports compliance with cGMP and ISO standards for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to minimize exposure to moisture. For long-term storage, consider storing under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.